‘Free Speech’ is Harming Society: What is the Answer?
Or why the free speech absolutists just might be wrong
Related Articles
Quectel Achieves Certification from Skylo for NTN BG95-S5 Module
Skylo Certifies Quectel’s Latest Satellite Module, Expanding IoT Horizons
Global Atopic Dermatitis Among Children Projected to Rise Over 50 Years
This analysis using worldwide data from GBD 2021 indicates that the global burden of eczema in children has gradually risen and has been projected to…
Beyond 5G: New optical modulator can operate at 10 times the speed of current devices
Kyushu University researchers have successfully developed an ultra-high-speed optical modulator that can operate at more than 10 times the speed of current devices. This modulator…
Exercise Medicine Helps Patient With ‘Osteobesity’ Avoid Knee Replacement
A patient with class 3 obesity no longer needs knee replacement after reducing her BMI to 26 with exercise medicine and anti-obesity drugs.
How hard is it to prevent recurring blackouts in Puerto Rico? A novel framework for grid resiliency
Researchers at MIT’s Laboratory for Information and Decision Systems (LIDS) have shown that using decision-making software and dynamic monitoring of weather and energy use can…
Enterprise Tech Predictions for 2025
As 2025 begins, I find that the global technology landscape is on the cusp of entering a major new era. It’s one almost totally defined…
Trends of acute respiratory infection, including human metapneumovirus, in the Northern Hemisphere
In many countries of the Northern Hemisphere, trends in acute respiratory infections increase at this time of year. These increases are typically caused by seasonal…
Prime Healthcare Foundation to acquire Central Maine Healthcare
Central Maine Healthcare facilities would keep their names and local leadership post-transaction.
Henry Ford Health Named Official Team Physicians of Detroit Red Wings
Henry Ford Health and Detroit Red Wings logos
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma | NEJM
Talquetamab (anti–G protein–coupled receptor family C group 5 member D) and teclistamab (anti–B-cell maturation antigen) are bispecific antibodies that activate T cells by targeting CD3…
